Cancer: Cancer and telomeres - An alternative to telomerase

Jerry W. Shay, Roger R. Reddel, Woodring E. Wright

Research output: Contribution to journalShort surveypeer-review

88 Scopus citations


Finding ways to target the alternative (ALT) telomere lengthening pathway found in some cancer cells could complement telomerase inhibitors currently in clinical trials.

Original languageEnglish (US)
Pages (from-to)1388-1390
Number of pages3
Issue number6087
StatePublished - Jun 15 2012

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Cancer: Cancer and telomeres - An alternative to telomerase'. Together they form a unique fingerprint.

Cite this